
Retreatment Efficacy of 177Lu-DOTATATE: A U.S. Center’s Findings
Recent advancements have broadened the spectrum of treatments for advanced NETs, encompassing a range of therapies that include peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE.